Cooper Graham K
SEC-identified person · CIK 1396943 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Beam Therapeutics Inc. BEAM | Director | filed 2020 - 2026 |
| Kezar Life Sciences, Inc. KZR | Director | filed 2018 - 2026 |
| Applied Molecular Transport Inc. AMTI | Director | filed 2020 - 2022 |
| Unity Biotechnology, Inc. UBX | Director | filed 2018 - 2021 |
| Panacea Acquisition Corp PANA | Director | filed 2020 - 2021 |
| Ventrus Biosciences INC VTUS | See Remarks | filed 2018 - 2019 |
| Receptos, Inc. RCPT | Chief Financial Officer | filed 2013 - 2015 |
| Eiger Biopharmaceuticals, Inc. EIGR | Director | filed 2014 - 2015 |
| Geron Corp GERN | EVP, Bus Dev & CFO | filed 2012 - 2012 |
| Orexigen Therapeutics, Inc. OREXQ | CFO, Treasurer, Secretary | filed 2007 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.